Avanos Medical (AVNS) Raw Materials (2014 - 2026)

Avanos Medical has disclosed Raw Materials across 13 years of filings, most recently posting $34.1 million for Q1 2026.

• In Q1 2026, Raw Materials fell 8.82% year-over-year to $34.1 million; the TTM figure through Mar 2026 stood at $34.1 million (down 8.82% YoY), while the FY2025 annual figure was $34.7 million, down 4.93% from the prior year.
• Raw Materials came in at $34.1 million for Q1 2026 at Avanos Medical, down from $34.7 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $57.0 million in Q1 2023 to a low of $34.1 million in Q1 2026.
• Average Raw Materials over 5 years is $43.7 million, with a median of $43.5 million recorded in 2023.
• Year-over-year, Raw Materials jumped 37.06% in 2023 and slipped 27.44% in 2024.
• Over 5 years, Raw Materials stood at $36.7 million in 2022, then soared by 37.06% to $50.3 million in 2023, then fell by 27.44% to $36.5 million in 2024, then fell by 4.93% to $34.7 million in 2025, then declined by 1.73% to $34.1 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $34.1 million in Q1 2026, $34.7 million in Q4 2025, and $37.1 million in Q3 2025.